MAPK1 and glomerulonephritis: ERK inhibition suppressed mesangial cell proliferation and reduced the renal damage in a rat model of experimental mesangioproliferative glomerulonephritis [69], and slowed the progression of renal disease in a murine model of polycystic kidney disease [70].